Search results
USFDA: Sun Pharma, Dr Reddy’s recall drugs in US market
Tribune India· 10 hours agoDr Reddy’s Laboratories and Sun Pharma are recalling products in the US due to manufacturing issues,...
Dr Reddy's Lab pushes the pedal to touch 1.5 billion patients by FY30
Business Standard India· 19 hours agoHyderabad-based pharma major Dr Reddy’s Laboratories (DRL) is targeting to reach 1.5 billion...
Stocks in news: HDFC Bank, IDFC First Bank, IDBI Bank, Dr Reddy's, Lloyds Metals
The Economic Times· 7 hours agoHDFC Bank advances rose 53% to Rs 24.87 lakh crore. LIC boosted IDFC First Bank's stake to 2.68%. Dr...
Dr Reddy's Laboratories Shares Rise After Acquiring Haleon’s Nicotine Replacement Therapy
Free Press Journal· 2 days agoHyderabad-based Dr Reddy Laboratories, one of the more-noticed names in the pharma business, has...
Dr Reddy's shares: Should you buy, sell or hold the pharma stock after Nicotinell's acquisition?
Business Today· 7 days agoBrokerage firms continue to remain mostly positive on Dr Reddy's Laboratories Ltd as the pharma...
Dr. Reddy’s, Sun Pharma recalling a drug each in U.S.
The Hindu· 16 hours agoSun Pharma is recalling 2,088 vials of cancer drug Decitabine for Injection 50mg per vial manufactured by the company in Halol, Gujarat
Zydus Life, Dr Reddy's partner to co-market Pertuzumab biosimilar for breast cancer treatment - CNBC...
CNBC TV18· 7 days agoGeneric drugmaker Zydus Lifesciences Ltd on Friday (June 28) said it has entered into a licensing...
Why everyone is not convinced about Dr Reddy’s latest acquisition
CNBC Awaaz· 3 days agoDr Reddy’s will have to invest significantly to improve growth rates of the acquired brands in...
Buy Dr. Reddy's Laboratories, target price Rs 6500: Prabhudas Lilladher
The Economic Times· 4 days agoDr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 106802.89 Crore) operating in Pharmaceuticals sector.
Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Business Standard India· 2 days agoShares of pharmaceutical companies were in focus, and rallied up to 12 per cent on the BSE in...